|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | A randomized trial of bevaci-zumab,an anti-vascular endothelial growth factor antibody,for meta-static renal cancer显示文摘 | Yang JC Haworth L Sherry RM | | 0，，： | 1 |
| 2 | Randomized study of high-dose and low-dose interleukin-2 in patients with metastatic renal cancer显示文摘 | YANG JC SHERRY RM STEINBERG SM | 2003 | J Clin Oncol2003，21，： | 1 |
| 3 | Interleukin-10 is associated with the development of sepsis in trauma patients显示文摘 | Cue JI Goddard JK | 1996 | Trauma1996，40，4： | 1 |
| 4 | Randomized study of high-dose and low-dose interleukin-2 in patients with metastatic renal cancer显示文摘 | Yang JC Sherry RM Stienberg SM | 2003 | J Clin Oncol2003，21，16： | 1 |
| 5 | A randomized trial of bevacizumab,an anti-VEGF antibody,for metastatic renal cancer显示文摘 | Yang JC Haworth L Sherry RM | 2003 | N Engl J Med2003，349，5： | 1 |
| 6 | A randomized trial 9f bevacizumab,an anti-vascular endothelial growth factor tntibody,for metastatic renal cancer显示文摘 | Yang JC Haworth L Sherry RM et a/ | 2003 | N Engl J Med2003，349，5： | 1 |
| 7 | A randomized trial of beva- ci-zumab, ananti-vascular endothelial growth factor antibody, for meta- static renal cancer显示文摘 | Yang JC Haworth L Sherry RM | 2003 | N Engl J Med2003，349，5： | 1 |
| 8 | Durable complete responses in heavily pretreated patients with metastatic melanoma using T-cell transfer immunotherapy显示文摘 | Rosenberg SA Yang JC Sherry RM | 2011 | Clin Cancer Res2011，17，13： | 1 |
| 9 | Durable complete responses in heavily pretreated patients with metastatic melanoma using T-cell transfer immunotherapy显示文摘 | Rosenberg SA Yang JC Sherry RM | 2011 | Clin Cancer Res2011，17，13： | 1 |
| 10 | A randomized trial ofbevacizumab, an anti-vascular endothelial growth factor antibody, for metastatic renal cancer显示文摘 | Yang JC Haworth L Sherry RM | 2003 | N Engl J Med2003，349，5： | 1 |
| 11 | A randomized trial of bevacizumab, an anti-vascular endothelial growth factor antibody, for metastatic renal cancer显示文摘 | Yang JC Haworth L Sherry RM | 2003 | N Engl J Med2003，349，5： | 1 |
| 12 | A randomized trial of bevaeizumab, an anti-vascular endothelial growth factor an- tibody, for metastatic renal cancer显示文摘 | Yang JC Haworth L Sherry RM | 2003 | N Engl J M ed2003，349，5： | 1 |
| 13 | A randomized trial of bevacizumab,an anti-vascular endothelial growth factor antibody,for metastatic renal cancer显示文摘 | Yang JC Haworth L Sherry RM | 2003 | N Engl J Med2003，349，： | 1 |
| 14 | CTLA-4 blockade with ipilimumab:long-term follow-up of 179 patients with metastatic melanoma显示文摘 | Prieto PA Yang JC Sherry RM | 2012 | Clin Cancer Res2012，18，7： | 1 |
| 15 | A randomized trial of bevacizumab, an anti-vascular endothelial growth factor antibody, for metastatic renal cancer 显示文摘 | Yang JC Haworth L Sherry RM | 2003 | N Engl J Med2003，349，5： | 1 |
| 16 | A randomized trial of bevacizumah , an anti-vascular endothelial growth factor antibody, for metastatic renal cancer 显示文摘 | Yang J C Haworth L Sherry RM | 2003 | N Engl J Med2003，349，5： | 1 |
| 17 | Cancer regression and autoimmunity induced by cytotoxie T lymphocyte-associated antigen 4 blockade in patients with metastatic melanoma显示文摘 | Phan GQ Yang JC Sherry RM | 2003 | Proc Natl Acad Sci USA2003，100，14： | 1 |
| 18 | A randomized trial of bevacizumab,an anti-vascular endothelial growth factor antibody,for metastatic renal cancer显示文摘 | Yang JC Haworth L Sherry RM | | 0，，05： | 1 |
| 19 | A randomized trial of bevacizumab, an anti-vascular endothelial growth factor anti- body for metastatic renal cancer显示文摘 | Yang JC Haworth L Sherry RM | 2003 | N Engl J Med2003，349，5： | 1 |
| 20 | Durable complete responses in heavily pretreated patients with metastatic melanoma using T-cell transfer immunotherapy 显示文摘 | Rosenberg SA Yang JC Sherry RM | 2011 | Clin Cancer Res2011，17，13： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员